Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
BME
11:35:11 2026-10-12 am EDT
|
5-day change | 1st Jan Change | ||
| 58.50 EUR | +0.78% |
|
+2.54% | -7.87% |
| Oct. 05 | Spanish stocks - Factors to watch on Oct 5 | RE |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 2.99B 3.34B 2.79B 2.53B 4.77B 319B 4.8B 33.52B 13.12B 165B 12.55B 12.28B 531B | P/E 2026 * |
19.8x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.98B 3.33B 2.78B 2.52B 4.76B 319B 4.79B 33.42B 13.08B 164B 12.52B 12.24B 529B | EV / Sales 2026 * |
3.85x | EV / Sales 2027 * | 3.27x |
| Free-Float |
31.63% | Yield 2026 * |
1.66% | Yield 2027 * | 1.99% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
Tradegate
| 41L | Real-time | |
|
OTC Markets
| LABF.F | Delayed | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| Jul. 23 | Spanish stocks - Factors to watch on July 23 | RE |
| Feb. 25 | Spanish stocks - Factors to watch on Feb 25 | RE |
| Nov. 06 | Spanish stocks - Factors to watch on Nov 6 | RE |
| 25-03-05 | Spanish stocks - Factors to watch on March 5 | RE |
| 1 day | +0.78% | ||
| 1 week | +2.54% | ||
| Current month | -0.51% | ||
| 1 month | +2.01% | ||
| 3 months | +4.46% | ||
| 6 months | -29.81% | ||
| Current year | -7.87% |
| 1 week | 57.9 |  | 59.3 |
| 1 month | 56.55 | | 60.7 |
| Current year | 53.1 | | 86.7 |
| 1 year | 53.1 | | 86.7 |
| 3 years | 45.52 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/23/23 | Buy | Director | 1,000 | 0.0019% | ||
| 4/13/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 3/15/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.78% | +2.54% | +2.36% | +8.03% | 3.32B | |
| +0.28% | +3.46% | +41.89% | +93.71% | 1,051B | |
| +0.88% | +4.27% | +38.28% | +68.70% | 630B | |
| +1.68% | +5.78% | +21.96% | +89.56% | 489B | |
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | |
| +0.61% | +3.18% | +24.05% | +42.46% | 344B | |
| +0.72% | +2.99% | +14.29% | +34.71% | 272B | |
| +0.23% | +2.23% | -5.91% | +8.15% | 246B | |
| +0.65% | +3.62% | +43.93% | +46.50% | 224B | |
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | |
| Average | +0.47% | +3.05% | +27.84% | +52.82% | 380.7B | |
| Weighted average by Cap. | +0.41% | +3.17% | +34.05% | +66.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 865M 722M 654M 1.23B 82.66B 1.24B 8.67B 3.39B 42.65B 3.25B 3.18B 137B | 892M 997M 832M 755M 1.42B 95.3B 1.43B 10B 3.91B 49.18B 3.74B 3.66B 158B |
| Net income | 146M 163M 136M 124M 233M 15.62B 235M 1.64B 641M 8.06B 614M 600M 25.93B | 173M 193M 161M 146M 276M 18.46B 277M 1.94B 758M 9.53B 725M 709M 30.66B |
| Net Debt | -8.5M -9.49M -7.92M -7.19M -13.55M -908M -13.64M -95.22M -37.27M -468M -35.66M -34.87M -1.51B | -72.51M -81M -67.59M -61.31M -116M -7.74B -116M -812M -318M -4B -304M -298M -12.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-12 | €58.50 | +0.78% | 62,910 |
| 26-10-09 | €58.05 | -0.17% | 56,180 |
| 26-10-08 | €58.15 | -1.44% | 120,294 |
| 26-10-07 | €59.00 | +1.46% | 100,493 |
| 26-10-06 | €58.15 | +1.93% | 90,765 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
